Meta-analysis of gene expression microarrays with missing replicates

BMC Bioinformatics

Volumn 12, Issue , 2011, Pages

  Shi, Fan ^a   Abraham, Gad ^a   Leckie, Christopher ^a   Haviv, Izhak ^b   Kowalczyk, Adam ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; DIFFERENTIALLY EXPRESSED GENE; EFFECTIVE APPROACHES; FALSE DISCOVERY RATE; GASTRIC CANCERS; GENE EXPRESSION MICROARRAY; MICROARRAY EXPERIMENTS; STATISTICAL SIGNIFICANCE;

DISEASES; GENE EXPRESSION; MICROARRAYS; PROBES;

EXPERIMENTS;

ARTICLE; DNA MICROARRAY; GENE EXPRESSION PROFILING; META ANALYSIS (TOPIC); METHODOLOGY; STATISTICAL MODEL;

GENE EXPRESSION PROFILING; LINEAR MODELS; META-ANALYSIS AS TOPIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 79953089162     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-12-84     Document Type: Article

References (46)

1. Warnat P, Eils R, Brors B. Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes. BMC Bioinformatics 2005, 6:265+. 10.1186/1471-2105-6-265, 1312314, 16271137.
2. Xu L, Geman D, Winslow R. Large-scale integration of cancer microarray data identifies a robust common cancer signature. BMC Bioinformatics 2007, 8:275+. 10.1186/1471-2105-8-275, 1950528, 17663766.
3. Xu L, Tan AC, Winslow RL, Geman D. Merging microarray data from separate breast cancer studies provides a robust prognostic test. BMC Bioinformatics 2008, 9:125+. 10.1186/1471-2105-9-125, 2409450, 18304324.
4. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis 1985, Academic Press. San Diego, CA, USA.
5. Rhodes DR, Barrette TR, Rubin MA, Ghosh D, Chinnaiyan AM. Meta-Analysis of Microarrays: Interstudy Validation of Gene Expression Profiles Reveals Pathway Dysregulation in Prostate Cancer. Cancer Research 2002, 62(15):4427-4433.
6. Choi JK, Yu U, Kim S, Yoo OJ. Combining multiple microarray studies and modeling interstudy variation. Bioinformatics 2003, 19(Suppl 1).
7. Borozan I, Chen L, Paeper B, Heathcote JE, Edwards AM, Katze M, Zhang ZL, Mcgilvray ID. MAID: An effect size based model for microarray data integration across laboratories and platforms. BMC Bioinformatics 2008, 9:305+. 10.1186/1471-2105-9-305, 2483727, 18616827.
8. Marot G, Foulley J, Mayer C, Jaffrezic F. Moderated effect size and P-value combinations for microarray meta-analyses. Bioinformatics 2009, 25(20):2692-2699. 10.1093/bioinformatics/btp444, 19628502.
9. Breitling R, Armengaud P, Amtmann A, Herzyk P. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Letters 2004, 573(1-3):83-92. 10.1016/j.febslet.2004.07.055, 15327980.
10. Lai Y, Eckenrode SE, She JX. A statistical framework for integrating two microarray data sets in differential expression analysis. BMC bioinformatics 2009, 10(Suppl 1). 10.1186/1471-2105-10-S1-S23, 2648727, 19208123.
11. Shen K, Tseng GC. Meta-analysis for pathway enrichment analysis when combining multiple genomic studies. Bioinformatics 2010, 26(10):1316-1323. 10.1093/bioinformatics/btq148, 20410053.
12. Wren JD. A global meta-analysis of microarray expression data to predict unknown gene functions and estimate the literature-data divide. Bioinformatics 2009, 25(13):1694-1701. 10.1093/bioinformatics/btp290, 2732319, 19447786.
13. Ghosh D, Barette TR, Rhodes D, Chinnaiyan AM. Statistical issues and methods for meta-analysis of microarray data: a case study in prostate cancer. Functional & Integrative Genomics 2003, 3(4):180-188.
14. Petersen D, Chandramouli G, Geoghegan J, Hilburn J, Paarlberg J, Kim C, Munroe D, Gangi L, Han J, Puri R, Staudt L, Weinstein J, Barrett JC, Green J, Kawasaki E. Three microarray platforms: an analysis of their concordance in profiling gene expression. BMC Genomics 2005, 6:63. 10.1186/1471-2164-6-63, 1140753, 15876355.
15. Boussioutas A. Distinctive Patterns of Gene Expression in Premalignant Gastric Mucosa and Gastric Cancer. Cancer Research 2003, (63):2569-2577.
16. Ji JF, Chen X, Leung SY, Chi JA, Chu KM, Yuen ST, Li R, Chan AS, Li JY, Dunphy N, So S. Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines. Oncogene 2002, 21:6549-6556. 10.1038/sj.onc.1205829, 12226758.
17. Hippo Y, Taniguchi H, Tsutsumi S, Machida N, Chong J, Fukayama M, Kodama T, Aburatani H. Global Gene Expression Analysis of Gastric Cancer by Oligonucleotide Microarrays. Cancer Research 2002, 62:233-240.
18. Cochran WG. The Combination of Estimates from Different Experiments. Biometrics 1954, 10:101-129.
19. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. Series B (Methodological) 1995, 57:289-300.
20. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proceedings of the National Academy of Sciences of the United States America 2001, 98(9):5116-5121.
21. Lauren P. The two histological main types of gastric carcinoma: difiuseand so-called intestinal-type carcinoma. Acta Path Microbiol Scand 1965, 64:31-49.
22. Ramasamy A, Mondry A, Holmes CC, A DG. Key issues in conducting a meta-analysis of gene expression microarray datasets. PLoS medicine 2008, 5(9):e184+. 10.1371/journal.pmed.0050184, 2528050, 18767902.
23. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled clinical trials 1986, 7(3):177-188. 10.1016/0197-2456(86)90046-2, 3802833.
24. Arnold SF. The theory of linear models and multivariate analysis 1981, New York: Wiley.
25. Schafer JL. Analysis of Incomplete Multivariate Data. London: 1997, Chapman & Hall.
26. Aittokallio T. Dealing with missing values in large-scale studies: microarray data imputation and beyond. Brief Bioinformatics 2010, 11(2):253-264. 10.1093/bib/bbp059, 19965979.
27. Dempster AP, Laird NM, Rubin DB. Maximum Likelihood from Incomplete Data via the EM Algorithm. Journal of the Royal Statistical Society. Series B (Methodological) 1977, 39:1-38.
28. Rubin DB. Multiple Imputation for Nonresponse in Surveys 1987, New York: J. Wiley & Sons.
29. Stevens JR, Nicholas G. Metahdep: meta-analysis of hierarchically dependent gene expression studies. Bioinformatics (Oxford, England) 2009, 25(19):2619-2620. 10.1093/bioinformatics/btp468, 19648140.
30. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. Gene Ontology: tool for the unification of biology. Nature Genetics 2000, 25:25-29. 10.1038/75556, 3037419, 10802651.
31. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Research 2002, 30:207-210. 10.1093/nar/30.1.207, 99122, 11752295.
32. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, Talantov D, Timmermans M, Meijer-van Gelder ME, Yu J, Jatkoe T, Berns EM, Atkins D, Foekens JA. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. The Lancet 2005, 365:671-679.
33. Ivshina AV, George J, Senko O, Mow B, Putti TC, Smeds J, Lindahl T, Pawitan Y, Hall P, Nordgren H, Wong JE, Liu ET, Bergh J, Kuznetsov VA, Miller LD. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Research 2006, 66:10292-10301. 10.1158/0008-5472.CAN-05-4414, 17079448.
34. Loi S, Haibe-Kains B, Desmedt C, Lallemand F, Tutt AM, Gillet C, Ellis P, Harris A, Bergh J, Foekens JA, Klijn JGM, Larsimont D, Buyse M, Bontempi G, Delorenzi M, Piccart MJ, Sotiriou C. Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor-Positive Breast Carcinomas Through Genomic Grade. Journal of Clinical Oncology 2007, 25:1239-1246. 10.1200/JCO.2006.07.1522, 17401012.
35. Loi S, Haibe-Kains B, Desmedt C, Wirapati P, Lallemand F, Tutt AM, Gillet C, Ellis P, Ryder K, Reid JF, Daidone MG, Pierotti MA, Berns EM, Jansen MP, Foekens JA, Delorenzi M, Bontempi G, Piccart MJ, Sotiriou C. Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen. BMC Genomics 2008, 9. 10.1186/1471-2164-9-239, 2423197, 18498629.
36. Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, Haibe-Kains B, Viale G, Delorenzi M, Zhang Y, d'Assignies MS, Bergh J, Lidereau R, Ellis P, Harris AL, Klijn JG, Foekens JA, Cardoso F, Piccart MJ, Buyse M, Sotiriou C, Consortium T. Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clinical Cancer Research 2007, 13:3207-3214. 10.1158/1078-0432.CCR-06-2765, 17545524.
37. Schmidt M, Böhm D, von Törne C, Steiner E, Puhl A, Pilch H, Lehr HA, Hengstler JG, KÄolbl J, Gehrmann M. The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer. Cancer Research 2008, 68:5405-5413. 10.1158/0008-5472.CAN-07-5206, 18593943.
38. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AAM, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.
39. Mosley J, Keri R. Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists. BMC Medical Genomics 2008, 1:11+. 10.1186/1755-8794-1-11, 2396170, 18439262.
40. Dai HY, van't Veer L, Lamb J, He YD, Mao M, Fine BM, Bernards R, van de Vijver M, Deutsch P, Sachs A, Stoughton R, Friend S. A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. Cancer Research 2005, 65(10):4059-4066. 10.1158/0008-5472.CAN-04-3953, 15899795.
41. Beissbarth T, Speed TP. GOstat: find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics 2004, 20(9):1464-1465. 10.1093/bioinformatics/bth088, 14962934.
42. Tahara E. Molecular biology of gastric cancer. World Journal of Surgery 1995, 19(4):484-488. 10.1007/BF00294705, 7676688.
43. Yonemura Y, Endo Y, Fujita H, Fushida S, Ninomiya I, Bandou E, Taniguchi K, Miwa K, Ohoyama S, Sugiyama K, Sasaki T. Role of Vascular Endothelial Growth Factor C Expression in the Development of Lymph Node Metastasis in Gastric Cancer. Clinical Cancer Research 1999, 5(7):1823-1829.
44. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor Cell Interactions with the Extracellular Matrix During Invasion and Metastasis. Annual Review of Cell Biology 1993, 9:541-573. 10.1146/annurev.cb.09.110193.002545, 8280471.
45. Crawford N, Walker R, Lukes L, Officewala J, Williams R, Hunter K. The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival. Clinical and Experimental Metastasis 2008, 25(4):357-369. 10.1007/s10585-008-9146-6, 2410042, 18301994.
46. Ahn CH, Kim YR, Kim SS, Yoo NJ, Lee SH. Mutational Analysis of TTK Gene in Gastric and Colorectal Cancers with Microsatellite Instability. Cancer Treatment and Research 2009, 41(4):224-228.